Navigating Regulatory Challenges in 2025: Strategic Insights

As the regulatory landscape evolves in 2025, pharmaceutical companies face both exciting opportunities and complex...

Regulatory Intelligence โ€“ January 2025

Staying ahead in the pharmaceutical industry means keeping pace with evolving regulations. EMA and CMDh...

Expert Regulatory Translation Services for Seamless Compliance

Pharmexonโ€™s expert translation team enhances products, communication, and value for clients by delivering high-quality translations...

๐Ÿ“š Strengthening Our Expertise: Product-Specific Guidance

At Pharmexon, we believe in fostering a culture of continuous learning to stay ahead in...

Regulatory Intelligence September – October 2024

The Pharmaceutical Industry is incredibly dynamic, with constant updates occurring all through various fields encompassing...

๐Ÿšจ Important Update from the European Medicines Agency (EMA) ๐Ÿšจ

This fall a significant EMA update of guideline on Environmental Risk Assessment (ERA) for Medicinal...

Pharmexon Company Breakfast

Only a couple of weeks ago, one of Pharmexonโ€™s favorite traditions occurredโ€” the Pharmexon Company...

๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฒ๐˜…๐—ผ๐—ป ๐—ต๐—ฎ๐—ฑ ๐˜๐—ต๐—ฒ ๐—ฝ๐—น๐—ฒ๐—ฎ๐˜€๐˜‚๐—ฟ๐—ฒ ๐—ผ๐—ณ ๐—ฎ๐˜๐˜๐—ฒ๐—ป๐—ฑ๐—ถ๐—ป๐—ด BioBridges Conference ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฐ ๐—ถ๐—ป ๐—ฃ๐—ฟ๐—ฎ๐—ด๐˜‚๐—ฒ!

From September 26th to 27th, the event brought together professionals in bioequivalence and pharmaceutical development,...

Pharmexonโ€™s team would like to extend our heartfelt appreciation to all our friends, clients and partners.

CPHI Milan provided an incredible platform for us to meet with both our longstanding friends,...